Attached files

file filename
EX-99.1 - EX-99.1 - AstroNova, Inc.d139328dex991.htm
EX-99.2 - EX-99.2 - AstroNova, Inc.d139328dex992.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 16, 2016

 

 

ASTRO-MED, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Rhode Island   0-13200   05-0318215

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

600 East Greenwich Avenue

West Warwick, RI 02893

(Address of principal executive offices) (Zip Code)

(401)-828-4000

Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On March 16, 2016, we issued a press release reporting our financial results for our fiscal fourth quarter and year ended January 31, 2016. A copy of the press release relating to such announcement, dated March 16, 2016 is attached hereto as Exhibit 99.1 and is incorporated herein by reference. On March 16, 2016, we posted investor presentation slides on our website discussing our financial results for the fiscal year and fiscal quarter ended January 31, 2016. A copy of the presentation is attached hereto as Exhibit 99.2.

The information contained in Item 2.02 of this report and Exhibits 99.1 and 99.2 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

(d) Exhibits

 

Exhibit
No.

  

Exhibit

99.1    Press Release Dated March 16, 2016
99.2    Presentation Slides Dated March 16, 2016

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ASTRO-MED, INC.
Dated: March 16, 2016     By:  

/s/ Joseph P. O’Connell

      Joseph P. O’Connell
     

Senior Vice President, Treasurer

and Chief Financial Officer

 

3


INDEX TO EXHIBITS

 

Exhibit
No.

  

Exhibit

99.1    Press Release Dated March 16, 2016
99.2    Presentation Slides Dated March 16, 2016

 

4